Article

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

2020-11-03

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: KRAS was reported to affect some metabolic genes and promote metabolic reprogramming in solid tumors. However, there is no comprehensive analysis to explore KRAS associated metabolic signature or risk model for Pancreatic cancer (PC).<bold>Methods</bold>: In current study, multiple bioinformatics analyses were used to identify differentially expressed metabolic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0006d567-d62c-56b7-afd9-f62564ada0a5
DOI: 10.21203/rs.3.rs-98504/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic CancerDOI 10.21203/rs.3.rs-98504/v1Read

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer.Semantic proximity Read

A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer.Semantic proximity Read

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis predictionSemantic proximity Read

Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristicsSemantic proximity Read

Metabolic Syndrome Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Carcinoma. A Novel Link Between Metabolic Dysregulation and Pancreatic Ductal Carcinoma.Semantic proximity Read

Identification of a glycolysis-related gene signature for predicting pancreatic cancer survivalSemantic proximity Read

Hypoxia- and Lactate Metabolism-Associated Prognostic and Therapeutic Signature in Pancreatic CancerSemantic proximity Read

Development and Validation of a Novel Glycolysis-Related Risk Signature for Predicting Survival in Pancreatic AdenocarcinomaSemantic proximity Read

The Prognostic Value of Metabolic Genes in Gastric AdenocarcinomaSemantic proximity Read

Identification Sixteen Metabolic Genes as Potential Biomarkers for Colon Adenocarcinoma Semantic proximity Read

Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data AnalysisSemantic proximity Read

Survival-associated Metabolic Genes in Colon and Rectal CancersSemantic proximity Read